课题基金 / 基金详情

HUMAN INSULIN ANALOGUE X14 & REGULAR HUMAN INSULIN AS MEAL RELATED INSULIN

HUMAN INSULIN ANALOGUE X14 & REGULAR HUMAN INSULIN AS MEAL RELATED INSULIN
人胰岛素类似物 X14
批准号:
6113013
负责人:
JANET MCGILL
金额:
$2.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

JANET MCGILL的其他基金

相似基金

相关文献

中文摘要
翻译
多中心开放标签非对称随机(1:1 X14对常规人胰岛素)试验,两个平行积极治疗组。之所以选择开放标签试验,是因为常规人胰岛素建议在饭前30分钟注射,而X14则是在饭前立即注射。盲法研究(双假人)意味着每个受试者每天注射的数量是不可接受的。固定的四周磨合期将确保所有受试者接受多次注射治疗方案,常规人胰岛素作为膳食相关胰岛素和NPH,人胰岛素作为基础胰岛素,并在随机化之前接受试验相关程序的培训。
英文摘要
Multicenter open-label asymmetrically randomized (1:1 X14 to Regular Human Insulin) trial with two parallel active treatment groups. An open-label trial has been chosen because Regular, Human Insulin is recommended to be injected 30 minutes before meals while X14 is to be injected immedialy before meals. Blinding the study (double dummy) would mean an unacceptable number of injections per subject per day. a fixed four week run-in period will ensure that all subjects are on a multiple injection treatment regimen with Regular, Human Insulin as meal related insulin and NPH, Human Insulin as basal insulin and trained in trial related procedures prior to randomization.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INTRA AND INTERSUBJECT VARIABILITY IN ABSORPTION OF SUBCUTANEOUS INSULIN
  • 批准号:
    6113031
  • 项目类别:
  • 资助金额:
    $2.44万
  • 财政年份:
    1998
  • 负责人:
    JANET MCGILL
  • 依托单位:
16 WEEK MULTICENTER CLINICAL TRIAL COMPARING H0E901 W/ NPH HUMAN INSULIN
  • 批准号:
    6113033
  • 项目类别:
  • 资助金额:
    $2.44万
  • 财政年份:
    1998
  • 负责人:
    JANET MCGILL
  • 依托单位:
EARLY DIABETES INTERVENTION PROGRAM (EDIP)
  • 批准号:
    6263500
  • 项目类别:
  • 资助金额:
    $2.44万
  • 财政年份:
    1998
  • 负责人:
    JANET MCGILL
  • 依托单位:
BRL49653C COMBINATION WITH GLYBURIDE TO PATIENTS WITH DIABETES
  • 批准号:
    6263498
  • 项目类别:
  • 资助金额:
    $2.44万
  • 财政年份:
    1998
  • 负责人:
    JANET MCGILL
  • 依托单位:
海外基金